News & Updates

Patients with symptomatic peripheral artery disease and type 2 diabetes see notable improvements in their walking capacity and quality of life with once-weekly semaglutide injections in the phase 3b STRIDE study.

Repeated microdosing of lysergic acid diethylamide (LSD) is not more efficacious than placebo in reducing attention-deficit/hyperactivity disorder (ADHD) symptoms in adults, a randomized controlled trial (RCT) has shown.

A rapid and persistent deterioration in cognitive function appears to occur following the onset of heart failure (HF), as reported in a study.

Data from the phase IV DUET* study presented at AAN 2025 reinforce the potential of low-sodium oxybate (LXB) for the treatment of narcolepsy or idiopathic hypersomnia (IH).